[1] Antibiotic resistance threats in the United States. 2013, Centers for Disease Control and Prevention.
[2] Acinetobacter baumannii infections among patients at military medical facilities treating injured U.S. service members, 2002-2004. MMWR Morb Mortal Wkly Rep, 2004. 53(45): p. 1063-6.
[3] Davis, K.A., et al., Multidrug-Resistant Acinetobacter Extremity Infections in Soldiers. Emerging Infectious Diseases, 2005. 11(8): p. 1218-1224.
[4] Howard, A., et al., Acinetobacter baumannii: an emerging opportunistic pathogen. Virulence, 2012. 3(3): p. 243-50.
[5] Turton, J.F., et al., Comparison of Acinetobacter baumannii Isolates from the United Kingdom and the United States That Were Associated with Repatriated Casualties of the Iraq Conflict. Journal of Clinical Microbiology, 2006. 44(7): p. 2630-2634.
[6] Rice, L.B., Challenges in identifying new antimicrobial agents effective for treating infections with Acinetobacter baumannii and Pseudomonas aeruginosa. Clin Infect Dis, 2006. 43 Suppl 2: p. S100-5.
[7] Alsan, M. and M. Klompas, Acinetobacter baumannii: An Emerging and Important Pathogen. Journal of clinical outcomes management : JCOM, 2010. 17(8): p. 363-369.
[8] Urban, C., S. Segal-Maurer, and J.J. Rahal, Considerations in Control and Treatment of Nosocomial Infections Due to Multidrug-Resistant Acinetobacter baumannii. Clinical Infectious Diseases, 2003. 36(10): p. 1268-1274.
[9] Harding, C.M., S.W. Hennon, and M.F. Feldman, Uncovering the mechanisms of Acinetobacter baumannii virulence. Nature Reviews Microbiology, 2018. 16(2): p. 91.
[10] WHO, Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. Geneva: World Health Organization, 2017.
[11] Pal, S., Y.K. Tak, and J.M. Song, Does the Antibacterial Activity of Silver Nanoparticles Depend on the Shape of the Nanoparticle? A Study of the Gram-Negative Bacterium Escherichia coli. Applied and Environmental Microbiology, 2007.
73(6): p. 1712-1720.
[12] Stoimenov, P.K., et al., Metal Oxide Nanoparticles as Bactericidal Agents. Langmuir, 2002. 18(17): p. 6679-6686.
[13] Li, P., et al., Synergistic antibacterial effects of β-lactam antibiotic combined with silver nanoparticles. Nanotechnology, 2005. 16(9): p. 1912- 1917.
[14] Chudobova, D., et al., Effect of Ampicillin, Streptomycin, Penicillin and Tetracycline on Metal Resistant and Non-Resistant Staphylococcus aureus. International Journal of Environmental Research and Public Health, 2014. 11(3): p. 3233-3255.
[15] Kohanski, M.A., D.J. Dwyer, and J.J. Collins, How antibiotics kill bacteria: from targets to networks. Nature reviews. Microbiology, 2010. 8(6): p. 423-435.
[16] Abdel Rahim, K.A. and A.M. Ali Mohamed, Bactericidal and Antibiotic Synergistic Effect of Nanosilver Against Methicillin-Resistant Staphylococcus aureus. Jundishapur J Microbiol, 2015. 8(11): p. e25867.
[17] Kim, S.-H., et al., Antibacterial activity of silver-
nanoparticles against Staphylococcus aureus
and Escherichia coli. Korean J. Microbiol. Biotechnol,
2011. 39(1): p. 77-85. http://dx.doi.org/10.31530/17028
[18] Gao, M., et al., Controlled synthesis of Ag nanoparticles with different morphologies and their antibacterial properties. Materials Science and Engineering: C, 2013. 33(1): p. 397-404.
[19] McShan, D., et al., Synergistic antibacterial effect of silver nanoparticles combined with ineffective antibiotics on drug resistant Salmonella typhimurium DT104. Journal of Environmental Science and Health, Part C, 2015. 33(3): p. 369-384.